Frailty as an INstrument for Evaluation of Elderly Patients With Non ST Elevation Myocardial Infarction (NSTEMI) (FINE75+)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Linkoeping University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Medical Research Council
Information provided by:
Linkoeping University
ClinicalTrials.gov Identifier:
NCT01049997
First received: January 14, 2010
Last updated: February 9, 2011
Last verified: February 2011

January 14, 2010
February 9, 2011
October 2009
June 2011   (final data collection date for primary outcome measure)
The composite of death from any cause, myocardial infarction, revascularization due to ischemia, hospitalization from any cause, major bleeding, stroke/TIA and need for dialysis by one month after inclusion. [ Time Frame: One month after inclusion ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01049997 on ClinicalTrials.gov Archive Site
The composite of major bleeding, stroke/TIA and need for dialysis by one month after inclusion. [ Time Frame: One month after inclusion ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Frailty as an INstrument for Evaluation of Elderly Patients With Non ST Elevation Myocardial Infarction (NSTEMI)
Frailty as an INstrument for Evaluation of Elderly Patients With Non ST Elevation Myocardial Infarction (NSTEMI)

The purpose of this study is to describe patients, 75 years old or older, with Non ST Elevation Myocardial Infarction (NSTEMI) especially regarding the following variables: cardiovascular risk, co-morbidity and frailty. The investigators hypothesize that the degree of frailty influences the benefit from coronary angiography and the possible invasive treatment which can follow.

The term frailty denotes a multi-dimensional syndrome characterized by increased vulnerability and decreased physiologic reserves. Frailty stratification predicts a patient's risk of death and need for institutional care. The construct is well validated, but there is not one single accepted operational definition. The CSHA Clinical Frailty Scale (CFS) is a 7-point scale relying on clinical judgement. It is a global clinical measure of biological age, and it mixes co-morbidity, disability and cognitive impairment.Though frailty instruments so far mainly have been used in a geriatric context, it has been pointed out as relevant for cardiologic patients as well, e.g. regarding risk stratification for elderly patients with NSTEMI. The purpose of this study is to describe patients, 75 years old or older, with Non ST Elevation Myocardial Infarction (NSTEMI) especially regarding the following variables: cardiovascular risk, co-morbidity and frailty. The investigators hypothesize that the degree of frailty influences the benefit from coronary angiography and the possible invasive treatment which can follow.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Consecutive evaluable patients, 75 years old or older, with diagnosed NSTEMI, and cared for at one of the following hospital care units in the University Hospital of Linköping and the County Hospitals in Trollhättan (NÄL-Uddevalla) and Jönköping (Ryhov): cardiology, acute medicine, geriatrics, other internal medicine unit.

  • Non-ST Elevation Myocardial Infarction (NSTEMI)
  • Frailty
Not Provided
NSTEMI75+
Patients, 75 years old or older, with Non ST Elevation Myocardial Infarction (NSTEMI)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
300
June 2011
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients, 75 years old or older, with diagnosed NSTEMI, and cared for at one of the following hospital care units: cardiology, acute medicine, geriatrics, other internal medicine unit.

Exclusion Criteria:

  • Not willing to participate.
  • Non-evaluable patient due to communication problems and insufficient clinical information for the judgement of frailty (CFS).
Both
75 Years and older
No
Contact: Niklas G Ekerstad, MD +46 (0)13 222000 niklas.ekerstad@liu.se
Contact: Per Carlsson, Professor +46 (0)13 224992 per.carlsson@liu.se
Sweden
 
NCT01049997
FINE75+
Yes
Professor Per Carlsson, Linkoeping University, Sandbäcksgatan 7,58183 Linkoeping, Sweden
Linkoeping University
Medical Research Council
Principal Investigator: Niklas G Ekerstad, MD Linkoeping University, Sandbäcksgatan 7, 58183 Linkoeping, Sweden
Principal Investigator: Joakim Alfredsson, PhD Department of Cardiology, University Hospital of Linkoeping, 58183 Linkoeping, Sweden
Principal Investigator: Marcus Lindenberger, PhD Department of Cardiology, County Hospital Ryhov, 551 85 Joenkoeping, Sweden
Linkoeping University
February 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP